JFrog (NASDAQ:FROG – Free Report) had its price objective lifted by JPMorgan Chase & Co. from $100.00 to $115.00 in a research report sent to investors on Friday,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. Other equities research analysts have also issued reports about the stock. Needham & Company […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | JFrog (NASDAQ:FROG) Price Target Raised to $90.00 | 0 | 11.13 | 10-08-2026 |
| 2 | Target (NYSE:TGT) Price Target Raised to $157.00 | 0 | 13.85 | 10-08-2026 |
| 3 | TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00 | 0 | 13.04 | 10-08-2026 |
| 4 | JPMorgan Chase & Co. Cuts Zoetis (NYSE:ZTS) Price Target to $115.00 | 0 | 12.26 | 10-08-2026 |
| 5 | Natera (NASDAQ:NTRA) Price Target Raised to $360.00 | 0 | 14.27 | 10-08-2026 |
| 6 | Cadre (NYSE:CDRE) Price Target Raised to $45.00 | 0 | 13.85 | 10-08-2026 |
| 7 | Liberty Media Corporation – Liberty Formula One Series C (NASDAQ:FWONK) Price Target Raised to $125.00 | 0 | 12.59 | 10-08-2026 |
| 8 | Replimune Group (NASDAQ:REPL) Price Target Raised to $20.00 | 0 | 13.83 | 10-08-2026 |
| 9 | Genpact (NYSE:G) Price Target Raised to $45.00 | 0 | 14.26 | 10-08-2026 |
| 10 | Once Upon A Farm (NYSE:OFRM) Price Target Raised to $26.00 | 0 | 12.63 | 10-08-2026 |